Literature DB >> 28107874

Correlation of RUNX3 expression with microvessel density in colorectal adenocarcinoma tissues and clinical significance.

Jun Xue1, Xue-Liang Wu2, Xian-Tao Huang2, Ming Qu2, Fei Guo2, Guang-Yuan Sun2, Peng-Cheng Zhang2, Lei Han2, Li-Ming Pan2.   

Abstract

OBJECTIVE: To study the expression of RUNX3 in colorectal adenocarcinoma tissues and its correlation with microvessel density (MVD), and investigate the clinical pathological prognostic significance of RUNX3 and MVD in patients with colorectal cancer.
METHODS: The expression value of RUNX3 and MVD in 70 specimens' colorectal adenocarcinoma tissues were detected by immunohistochemistry staining technique. The correlation between their expression and the clinicopathologic features was also investigated.
RESULTS: The expression value of RUNX3 and the positive rates of RUNX3 in colorectal adenocarcinoma tissues were 3.25 ± 1.14 and 25.71% (18/70). The expression value of MVD in colorectal adenocarcinoma tissues was 13.14 ± 3.23. Expression of RUNX3 and MVD value were correlated with CEA, serosal invasion, liver metastasis, lymph node metastasis, and TNM stage (P < 0.01). The expression value of RUNX3 had negative correlations with that of MVD.
CONCLUSIONS: The high expression of RUNX3 could inhibit tumor microvascular generation in order to have negative control response on invasion and distant metastasis.
Copyright © 2017 Hainan Medical University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical significance; Colorectal neoplasms; Microvessel density; RUNX3

Year:  2016        PMID: 28107874     DOI: 10.1016/j.apjtm.2016.11.010

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  7 in total

1.  Expression, clinical significance and correlation of RUNX3 and HER2 in colorectal cancer.

Authors:  Yunshi Wu; Jun Xue; Yuanrui Li; Xueliang Wu; Ming Qu; Dandan Xu; Yongquan Shi
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition.

Authors:  Jianbo Zheng; Yanhui Mei; Ping Xiang; Guangsheng Zhai; Ning Zhao; Chuanbing Xu; Min Liu; Zhengsheng Pan; Kai Tang; Dongsheng Jia
Journal:  Cancer Cell Int       Date:  2018-04-10       Impact factor: 5.722

3.  Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma.

Authors:  Xianyun Zhang; Jindong Ji; Guangbo Zhang; Chuntao Fang; Fujin Jiang; Song Ma; Jianquan Hou
Journal:  Onco Targets Ther       Date:  2017-11-13       Impact factor: 4.147

4.  Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.

Authors:  Likun Wang; Xueliang Wu; Wengui Xu; Lei Gao; Ximo Wang; Tian Li
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

5.  Methylation-dependent transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse cardiac microvascular endothelial cell viability and inflammatory response following myocardial infarction.

Authors:  Yanbin Wang; Xudong Yang; An Jiang; Wei Wang; Jian Li; Junmin Wen
Journal:  FASEB J       Date:  2019-10-18       Impact factor: 5.834

6.  Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.

Authors:  Xiaohui Chen; Yujie Deng; Yi Shi; Weifeng Zhu; Yibin Cai; Chunwei Xu; Kunshou Zhu; Xiongwei Zheng; Gang Chen; Qi Xie; Guoxing Weng
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

7.  RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.

Authors:  Jun Xue; Xueliang Wu; Ming Qu; Fei Guo; Lei Han; Guangyuan Sun; Zelong Yuan; Shuang Fan; Tian Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-27       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.